Research on innovative ingredients for the prevention of colon cancer and dyslipemias

The CDTI has published a provisional resolution regarding the projects presented to the program Strategic Sectoral Initiatives for Business Innovation ( CDTI Missions ), within the framework of the E.P. Business Leadership in R+D+i, and BDI biotech together with other companies has presented one of the projects approved with the research in the meat products of the future aimed at the prevention of colon cancer and dyslipemias.

If you want to know more you can take a look to this link:

https://www.dihbu40.es/el-cdti-aprueba-los-primeros-proyectos-id-del-programa-misiones/

Next post
BDI biotech
Privacy Overview

This website uses cookies so that we can provide you with the best possible user experience. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our site or helping our team understand which sections of the site you find most interesting and useful.